"Monophenol Monooxygenase" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An enzyme of the oxidoreductase class that catalyzes the reaction between L-tyrosine, L-dopa, and oxygen to yield L-dopa, dopaquinone, and water. It is a copper protein that acts also on catechols, catalyzing some of the same reactions as CATECHOL OXIDASE. EC 1.14.18.1.
| Descriptor ID |
D014442
|
| MeSH Number(s) |
D08.811.682.690.708.125.500
|
| Concept/Terms |
Monophenol Monooxygenase- Monophenol Monooxygenase
- Monooxygenase, Monophenol
- Dopa Oxidase
- Oxidase, Dopa
- Phenol Oxidase
- Oxidase, Phenol
- Phenoloxidase
- Tyrosinase
- Cresolase
|
Below are MeSH descriptors whose meaning is more general than "Monophenol Monooxygenase".
Below are MeSH descriptors whose meaning is more specific than "Monophenol Monooxygenase".
This graph shows the total number of publications written about "Monophenol Monooxygenase" by people in this website by year, and whether "Monophenol Monooxygenase" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 1 | 0 | 1 |
| 2003 | 1 | 0 | 1 |
| 2006 | 0 | 2 | 2 |
| 2010 | 1 | 0 | 1 |
| 2012 | 0 | 1 | 1 |
| 2013 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2019 | 0 | 1 | 1 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Monophenol Monooxygenase" by people in Profiles.
-
Serrano-Gonz?lez J, Montes-Rodr?guez I, Renta JY, Rojas R, Cadilla CL. After an initial Hermansky-Pudlak syndrome clinical diagnosis, molecular testing reveals variants for oculocutaneous albinism type 1B: A case report. Mol Genet Genomic Med. 2024 Jul; 12(7):e2493.
-
Ojo OA, Afon AA, Ojo AB, Ajiboye BO, Okesola MA, Aruleba RT, Adekiya TA, Oyinloye BE. Spondias mombim L. (Anacardiaceae): Chemical fingerprints, inhibitory activities, and molecular docking on key enzymes relevant to erectile dysfunction and Alzheimer's diseases. J Food Biochem. 2019 03; 43(3):e12772.
-
Hu JJ, Bai XL, Liu YM, Liao X. Functionalized carbon quantum dots with dopamine for tyrosinase activity analysis. Anal Chim Acta. 2017 Dec 01; 995:99-105.
-
Ratzan W, Falco R, Salanga C, Salanga M, Horb ME. Generation of a Xenopus laevis F1 albino J strain by genome editing and oocyte host-transfer. Dev Biol. 2017 06 15; 426(2):188-193.
-
Washington C, Maxwell J, Stevenson J, Malone G, Lowe EW, Zhang Q, Wang G, McIntyre NR. Mechanistic studies of the tyrosinase-catalyzed oxidative cyclocondensation of 2-aminophenol to 2-aminophenoxazin-3-one. Arch Biochem Biophys. 2015 Jul; 577-578:24-34.
-
Rodr?guez-Agramonte F, Izquierdo NJ, Cadilla C. Ocular findings in patients with oculocutaneous albinism type ia with G47D tyrosinase gene mutation in Puerto Rico: a case report. Bol Asoc Med P R. 2013; 105(2):62-4.
-
de S? RO, Streicher JW, Sekonyela R, Forlani MC, Loader SP, Greenbaum E, Richards S, Haddad CF. Molecular phylogeny of microhylid frogs (Anura: Microhylidae) with emphasis on relationships among New World genera. BMC Evol Biol. 2012 Dec 10; 12:241.
-
Shirasugi I, Kamada M, Matsui T, Sakakibara Y, Liu MC, Suiko M. Sulforaphane inhibited melanin synthesis by regulating tyrosinase gene expression in B16 mouse melanoma cells. Biosci Biotechnol Biochem. 2010; 74(3):579-82.
-
Hasegawa T, Matsuzaki-Kobayashi M, Takeda A, Sugeno N, Kikuchi A, Furukawa K, Perry G, Smith MA, Itoyama Y. Alpha-synuclein facilitates the toxicity of oxidized catechol metabolites: implications for selective neurodegeneration in Parkinson's disease. FEBS Lett. 2006 Apr 03; 580(8):2147-52.
-
Santiago Borrero PJ, Rodr?guez-P?rez Y, Renta JY, Izquierdo NJ, Del Fierro L, Mu?oz D, Molina NL, Ram?rez S, Pag?n-Mercado G, Ort?z I, Rivera-Caragol E, Spritz RA, Cadilla CL. Genetic testing for oculocutaneous albinism type 1 and 2 and Hermansky-Pudlak syndrome type 1 and 3 mutations in Puerto Rico. J Invest Dermatol. 2006 Jan; 126(1):85-90.